Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 5jtb | ZMA | Adenosine receptor A2a |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 5jtb | ZMA | Adenosine receptor A2a | / | 1.000 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.662 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.660 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.654 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.641 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.636 | |
| 5iu8 | 6DZ | Adenosine receptor A2a | / | 0.623 | |
| 4eiy | ZMA | Adenosine receptor A2a | / | 0.620 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.615 | |
| 3eml | ZMA | Adenosine receptor A2a | / | 0.613 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.583 | |
| 5iu4 | ZMA | Adenosine receptor A2a | / | 0.555 | |
| 2ydv | NEC | Adenosine receptor A2a | / | 0.513 | |
| 5g53 | NEC | Adenosine receptor A2a | / | 0.505 | |
| 4ug2 | NGI | Adenosine receptor A2a | / | 0.500 | |
| 2ydo | ADN | Adenosine receptor A2a | / | 0.497 | |
| 3vg9 | ZMA | Adenosine receptor A2a | / | 0.487 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.486 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.467 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.461 | |
| 2rbe | NDP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.452 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.449 | |
| 3pwh | ZMA | Adenosine receptor A2a | / | 0.449 | |
| 1tw2 | ERT | Carminomycin 4-O-methyltransferase DnrK | 2.1.1.292 | 0.443 | |
| 4oxy | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.442 |